Cargando…

The effectiveness of the Allen Carr smoking cessation training in companies tested in a quasi-experimental design

BACKGROUND: The Allen Carr training (ACt) is a popular one-session smoking cessation group training that is provided by licensed organizations that have the permission to use the Allen Carr method. However, few data are available on the effectiveness of the training. METHODS: In a quasi-experimental...

Descripción completa

Detalles Bibliográficos
Autores principales: Dijkstra, Arie, Zuidema, Rixt, Vos, Diederick, van Kalken, Marike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189200/
https://www.ncbi.nlm.nih.gov/pubmed/25218267
http://dx.doi.org/10.1186/1471-2458-14-952
_version_ 1782338324501889024
author Dijkstra, Arie
Zuidema, Rixt
Vos, Diederick
van Kalken, Marike
author_facet Dijkstra, Arie
Zuidema, Rixt
Vos, Diederick
van Kalken, Marike
author_sort Dijkstra, Arie
collection PubMed
description BACKGROUND: The Allen Carr training (ACt) is a popular one-session smoking cessation group training that is provided by licensed organizations that have the permission to use the Allen Carr method. However, few data are available on the effectiveness of the training. METHODS: In a quasi-experimental design the effects of the existing practice of providing the ACt to smokers (n = 124) in companies on abstinence, were compared to changes in abstinence in a cohort of similar smokers in the general population (n = 161). To increase comparability of the smokers in both conditions, smokers in the control condition were matched on the group level on baseline characteristics (fourteen variables) to the smokers in the ACt. The main outcome measure was self-reported continuous abstinence after 13 months, which was validated using a CO measurement in the Act condition. RESULTS: Logistic regression analyses showed that when baseline characteristics were comparable, significantly more responding smokers were continuously abstinent in the ACt condition compared to the control condition, Exp(B) = 6.52 (41.1% and 9.6%, respectively). The all-cases analysis was also significant, Exp(B) = 5.09 (31.5% and 8.3%, respectively). CONCLUSION: Smokers following the ACt in their company were about 6 times more likely to be abstinent, assessed after 13 months, compared to similar smokers in the general population. Although smokers in both conditions did not differ significantly on 14 variables that might be related to cessation success, the quasi-experimental design allows no definite conclusion about the effectiveness of the ACt. Still, these data support the provision of the ACt in companies.
format Online
Article
Text
id pubmed-4189200
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41892002014-10-09 The effectiveness of the Allen Carr smoking cessation training in companies tested in a quasi-experimental design Dijkstra, Arie Zuidema, Rixt Vos, Diederick van Kalken, Marike BMC Public Health Research Article BACKGROUND: The Allen Carr training (ACt) is a popular one-session smoking cessation group training that is provided by licensed organizations that have the permission to use the Allen Carr method. However, few data are available on the effectiveness of the training. METHODS: In a quasi-experimental design the effects of the existing practice of providing the ACt to smokers (n = 124) in companies on abstinence, were compared to changes in abstinence in a cohort of similar smokers in the general population (n = 161). To increase comparability of the smokers in both conditions, smokers in the control condition were matched on the group level on baseline characteristics (fourteen variables) to the smokers in the ACt. The main outcome measure was self-reported continuous abstinence after 13 months, which was validated using a CO measurement in the Act condition. RESULTS: Logistic regression analyses showed that when baseline characteristics were comparable, significantly more responding smokers were continuously abstinent in the ACt condition compared to the control condition, Exp(B) = 6.52 (41.1% and 9.6%, respectively). The all-cases analysis was also significant, Exp(B) = 5.09 (31.5% and 8.3%, respectively). CONCLUSION: Smokers following the ACt in their company were about 6 times more likely to be abstinent, assessed after 13 months, compared to similar smokers in the general population. Although smokers in both conditions did not differ significantly on 14 variables that might be related to cessation success, the quasi-experimental design allows no definite conclusion about the effectiveness of the ACt. Still, these data support the provision of the ACt in companies. BioMed Central 2014-09-13 /pmc/articles/PMC4189200/ /pubmed/25218267 http://dx.doi.org/10.1186/1471-2458-14-952 Text en © Dijkstra et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Dijkstra, Arie
Zuidema, Rixt
Vos, Diederick
van Kalken, Marike
The effectiveness of the Allen Carr smoking cessation training in companies tested in a quasi-experimental design
title The effectiveness of the Allen Carr smoking cessation training in companies tested in a quasi-experimental design
title_full The effectiveness of the Allen Carr smoking cessation training in companies tested in a quasi-experimental design
title_fullStr The effectiveness of the Allen Carr smoking cessation training in companies tested in a quasi-experimental design
title_full_unstemmed The effectiveness of the Allen Carr smoking cessation training in companies tested in a quasi-experimental design
title_short The effectiveness of the Allen Carr smoking cessation training in companies tested in a quasi-experimental design
title_sort effectiveness of the allen carr smoking cessation training in companies tested in a quasi-experimental design
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189200/
https://www.ncbi.nlm.nih.gov/pubmed/25218267
http://dx.doi.org/10.1186/1471-2458-14-952
work_keys_str_mv AT dijkstraarie theeffectivenessoftheallencarrsmokingcessationtrainingincompaniestestedinaquasiexperimentaldesign
AT zuidemarixt theeffectivenessoftheallencarrsmokingcessationtrainingincompaniestestedinaquasiexperimentaldesign
AT vosdiederick theeffectivenessoftheallencarrsmokingcessationtrainingincompaniestestedinaquasiexperimentaldesign
AT vankalkenmarike theeffectivenessoftheallencarrsmokingcessationtrainingincompaniestestedinaquasiexperimentaldesign
AT dijkstraarie effectivenessoftheallencarrsmokingcessationtrainingincompaniestestedinaquasiexperimentaldesign
AT zuidemarixt effectivenessoftheallencarrsmokingcessationtrainingincompaniestestedinaquasiexperimentaldesign
AT vosdiederick effectivenessoftheallencarrsmokingcessationtrainingincompaniestestedinaquasiexperimentaldesign
AT vankalkenmarike effectivenessoftheallencarrsmokingcessationtrainingincompaniestestedinaquasiexperimentaldesign